Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Biologics : Targets & Therapy|February 28, 2020
Blinatumomab for the Treatment of Adult B-Cell Acute Lymphoblastic Leukemia: Toward a New Era of Targeted ImmunotherapyMiguel J Franquiz, Nicholas J ShortJournal of General Internal Medicine|September 15, 2020
Direct-to-Consumer Drug Advertisement and Prescribing Practices: Evidence Review and Practical Guidance for CliniciansMiguel J Franquiz, Amy L McGuireThe Annals of Pharmacotherapy|January 16, 2018
Comparison of Two Weight-Based Desmopressin Dosing Strategies for Spontaneous BleedingMiguel J Franquiz, Michelle C Hines, Siu Yan Amy YeungJournal of Critical Care|November 21, 2016
Clinical characteristics of critically ill patients with suspected influenza during the 2009-10 and 2013-14 outbreaksMiguel J Franquiz, Paul G Saleeb, Carl B Shanholtz, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 13, 2016
Drug-drug interactions in patients receiving tyrosine kinase inhibitorsKristine L Keller, Miguel J Franquiz, Alison P Duffy, et al.Pharmacotherapy|November 22, 2017
Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous HemofiltrationMiguel J Franquiz, Shamir N Kalaria, Michael J Armahizer, et al.JACC. Case Reports|August 10, 2026
Mitral Valve Malignant Glomus Tumor Presenting With Multiple Embolic EventsMiguel J Franquiz, Aravind Krishnan, Jesus R Lopez, et al.Acta Haematologica|April 15, 2020
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid LeukemiasAbhishek Maiti, Miguel J Franquiz, Farhad Ravandi, et al.Blood Advances|November 19, 2020
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemiaNicholas J Short, Guillermo Montalban-Bravo, Hyunsoo Hwang, et al.Pageof 1